About Replimune (REPL)
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are... Read more
- USD6.90
- USD7.07
- USD6.33
- USD24.81
- -21.90%
- --
- 866.79k
- 882.57k
- 438M
- 5.89
- -61.70%
Stock News
1 hour ago
Reed Hastings shares the 3-word tactic that helped make Netflix a $240 billion company—it's called 'farming for dissent'
CNBC
2 hours ago
S&P 500 Giants, Leading AI Play Among 5 Stocks To Watch In Tough Market
Yahoo
2 hours ago
If you’re investing in the AI theme for the long haul, here’s how to pick the winners
CNBC
2 hours ago
Why the oil market shrugged as Iran and Israel appeared on the brink of war this week
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
